TipRanks
Advertisement

DE:J409 ETF Price & Analysis

Compare

J409 ETF Chart & Stats

16.97
--
Market closed
16.97
--

ETF Overview

ProShares UltraShort Health Care

ProShares UltraShort Health Care (Ticker: RXD) is a dynamic exchange-traded fund (ETF) specifically designed for investors seeking amplified returns from the health care sector. As a leveraged ETF, RXD provides a unique opportunity by aiming to deliver twice the inverse (-2x) of the daily performance of the Dow Jones U.S. Health Care Index. This makes it an intriguing choice for those looking to capitalize on downturns within the health care industry. Categorized as a sector-focused ETF, RXD zeroes in on the expansive and ever-evolving health care landscape, which encompasses pharmaceuticals, biotechnology, medical devices, and health care services. This targeted approach allows investors to concentrate their portfolios on a critical and impactful sector, while the fund's broad-based niche ensures exposure to a diverse array of health care companies. Ideal for sophisticated investors with a bearish outlook on the health care market or those seeking to hedge their current exposure, RXD offers a powerful tool for tactical investments. However, due to its leveraged nature, the fund involves higher risk and is best suited for short-term strategies. Investors should thoroughly understand the implications of leveraged investing and monitor their positions closely. ProShares UltraShort Health Care encapsulates the potential for strategic gains in a complex and vital sector, providing an engaging option for those looking to navigate the intricacies of health care market movements.

ProShares UltraShort Health Care (J409) Fund Flow Chart

ProShares UltraShort Health Care (J409) 1 year Net Flows: 6M

J409 ETF FAQ

What was DE:J409’s price range in the past 12 months?
DE:J409 lowest ETF price was 14.59 and its highest was 18.90 in the past 12 months.
    What is the AUM of DE:J409?
    As of Oct 12, 2026 The AUM of DE:J409 is 3.49M.
      Is DE:J409 overvalued?
      Not enough analysts have published a price target to calculate whether the price is overvalued.
      Does DE:J409 pay dividends?
      DE:J409 does not currently pay dividends.
      How many shares outstanding does DE:J409 have?
      Currently, no data Available
      Which hedge fund is a major shareholder of DE:J409?
      Currently, no hedge funds are holding shares in DE:J409
      Popular ETFs
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis
      Advertisement